atorvastatin has been researched along with Arrhythmias, Cardiac in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (58.33) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bakhtiarian, A; Hojati, V; Mousavi, Z; Najjari, M; Nikoui, V; Vaezi, G | 1 |
Hu, SD; Qu, Y; Xia, JG; Xu, D; Xu, J; Yin, CL | 1 |
Bian, B; Nie, J; Teng, T; Wang, Q; Yu, X | 1 |
Chen, WR; Chen, YD; Liu, HB; Sha, Y; Shi, XM; Shi, Y; Wang, H; Yin, DW | 1 |
Angermann, C; Bauersachs, J; Frantz, S; Heinrich, F; Krane, V; Lilienthal, J; Meesmann, M; Olschewski, M; Störk, S; Wanner, C | 1 |
Bacova, B; Barancik, M; Knezl, V; Kolenova, L; Mitasikova, M; Navarova, J; Radosinska, J; Tribulova, N; Weismann, P | 1 |
Böhm, M; Fries, R | 1 |
Kumagai, K; Nakashima, H; Saku, K | 1 |
Esberg, D; Kowey, P | 1 |
Ferjan, M; Golicnik, A; Okrajsek, R; Radovancevic, B; Starc, V; Vrtovec, B | 1 |
Chen, L; Huang, J; Qian, H; Shen, D; Tang, Q; Wang, H; Wang, T; Wu, H; Xiong, R | 1 |
Dotani, MI; Elnicki, DM; Gibson, CM; Jain, AC | 1 |
1 review(s) available for atorvastatin and Arrhythmias, Cardiac
Article | Year |
---|---|
[Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure].
Topics: Abciximab; Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Antibodies, Monoclonal; Anticholesteremic Agents; Arrhythmias, Cardiac; Aspirin; Atorvastatin; Clopidogrel; Defibrillators, Implantable; Double-Blind Method; Fibrinolytic Agents; Heart Failure; Heart Septal Defects, Atrial; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic; Regeneration; Risk Factors; Syndrome; Ticlopidine; Time Factors; Tirofiban; Tyrosine | 2003 |
4 trial(s) available for atorvastatin and Arrhythmias, Cardiac
Article | Year |
---|---|
[Cardioprotective effect and mechanism of intensive lipid modulation on patients with coronary artery disease undergoing noncardiac surgery].
Topics: Anticholesteremic Agents; Arrhythmias, Cardiac; Atorvastatin; Brugada Syndrome; Cardiac Conduction System Disease; Coronary Artery Disease; Elective Surgical Procedures; Heart Conduction System; Heptanoic Acids; Humans; Lipids; Myocardial Infarction; Perioperative Period; Pyrroles | 2014 |
Effects of Statin on Arrhythmia and Heart Rate Variability in Healthy Persons With 48-Hour Sleep Deprivation.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Atorvastatin; C-Reactive Protein; Double-Blind Method; Electrocardiography; Female; Healthy Volunteers; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Male; Malondialdehyde; Sleep Deprivation; Superoxide Dismutase; Young Adult | 2016 |
Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis.
Topics: Aged; Arrhythmias, Cardiac; Atorvastatin; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Electrocardiography; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Kaplan-Meier Estimate; Male; Middle Aged; Practice Guidelines as Topic; Predictive Value of Tests; Proportional Hazards Models; Pyrroles; Renal Dialysis; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2009 |
Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atorvastatin; Electrocardiography; Female; Heart Failure; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Prospective Studies; Pyrroles; Statistics, Nonparametric; Survival Analysis; Treatment Outcome | 2005 |
7 other study(ies) available for atorvastatin and Arrhythmias, Cardiac
Article | Year |
---|---|
Involvement of IL-1β and IL-6 in antiarrhythmic properties of atorvastatin in ouabain-induced arrhythmia in rats.
Topics: Animals; Arrhythmias, Cardiac; Atorvastatin; Interleukin-1beta; Interleukin-6; Male; Ouabain; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2018 |
Atorvastatin protects myocardium against ischemia-reperfusion arrhythmia by increasing Connexin 43 expression: A rat model.
Topics: Animals; Arrhythmias, Cardiac; Atorvastatin; Connexin 43; Creatine Kinase, MB Form; Cytoprotection; Disease Models, Animal; Heart Rate; L-Lactate Dehydrogenase; Male; Myocardium; Phosphatidylinositol 3-Kinases; Phosphoproteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Up-Regulation | 2015 |
Omega-3 fatty acids and atorvastatin suppress ventricular fibrillation inducibility in hypertriglyceridemic rat hearts: implication of intracellular coupling protein, connexin-43.
Topics: Animals; Arrhythmias, Cardiac; Atorvastatin; Blood Pressure; Connexin 43; Fatty Acids, Omega-3; Heart Rate; Heart Ventricles; Heptanoic Acids; Hypertriglyceridemia; Myocardium; Myocytes, Cardiac; Phosphorylation; Pyrroles; Rats; Rats, Wistar; Triglycerides; Up-Regulation; Ventricular Fibrillation | 2010 |
The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model.
Topics: Animals; Arrhythmias, Cardiac; Atorvastatin; C-Reactive Protein; Dogs; Female; Heart Atria; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Models, Animal; Pericarditis; Pyrroles; Random Allocation | 2004 |
Does "anti-lipid" also mean "anti-arrhythmic"?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atorvastatin; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles | 2005 |
Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Atorvastatin; Autoimmune Diseases; Disease Models, Animal; Heart; Heart Ventricles; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-gamma; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Pyrroles; Tumor Necrosis Factor-alpha; Ventricular Function | 2007 |
Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting.
Topics: Aged; Anticholesteremic Agents; Arrhythmias, Cardiac; Atorvastatin; Cause of Death; Coronary Artery Bypass; Coronary Disease; Female; Heart Failure; Heptanoic Acids; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Preoperative Care; Pyrroles; Recurrence; Retrospective Studies; Risk Factors; Simvastatin; Stroke; Treatment Outcome | 2000 |